Business · 15/02/2019

FDA Announces Upcoming Meeting of Blood Products Advisory Committee

The Food and Drug Administration (FDA) is set to convene a public meeting of the Blood Products Advisory Committee (BPAC) to discuss regulatory issues related to blood and blood-derived products, including testing for Zika virus and research programs, with at least one portion closed to the public.